Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor

被引:372
作者
Schindler, T
Sicheri, F
Pico, A
Gazit, A
Levitzki, A
Kuriyan, J
机构
[1] Rockefeller Univ, Lab Mol Biophys, New York, NY 10021 USA
[2] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA
[3] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel
关键词
D O I
10.1016/S1097-2765(00)80357-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The crystal structure of the autoinhibited form of Hck has been determined at 2.0 Angstrom resolution, in complex with a specific pyrazolo pyrimidine-type inhibitor, PP1. The activation segment, a key regulatory component of the catalytic domain, is unphosphorylated and is visualized in its entirety. Tyr-416, the site of activating autophosphorylation in the Src family kinases, is positioned such that access to the catalytic machinery is blocked. PP1 is bound at the ATP-binding site of the kinase, and a methylphenyl group on PP1 is inserted into an adjacent hydrophobic pocket. The enlargement of this pocket in autoinhibited Src kinases suggests a route toward the development of inhibitors that are specific for the inactive forms of these proteins.
引用
收藏
页码:639 / 648
页数:10
相关论文
共 46 条
  • [1] CHARACTERIZATION OF PP60(C-SRC) TYROSINE KINASE-ACTIVITIES USING A CONTINUOUS ASSAY - AUTOACTIVATION OF THE ENZYME IS AN INTERMOLECULAR AUTOPHOSPHORYLATION PROCESS
    BARKER, SC
    KASSEL, DB
    WEIGL, D
    HUANG, XY
    LUTHER, MA
    KNIGHT, WB
    [J]. BIOCHEMISTRY, 1995, 34 (45) : 14843 - 14851
  • [2] Leukocyte protein tyrosine kinases: Potential targets for drug discovery
    Bolen, JB
    Brugge, JS
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 371 - 404
  • [3] Regulation, substrates and functions of src
    Brown, MT
    Cooper, JA
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1287 (2-3): : 121 - 149
  • [4] Crystallography & NMR system:: A new software suite for macromolecular structure determination
    Brunger, AT
    Adams, PD
    Clore, GM
    DeLano, WL
    Gros, P
    Grosse-Kunstleve, RW
    Jiang, JS
    Kuszewski, J
    Nilges, M
    Pannu, NS
    Read, RJ
    Rice, LM
    Simonson, T
    Warren, GL
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 : 905 - 921
  • [5] RIBBONS 2 0
    CARSON, M
    [J]. JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1991, 24 : 958 - &
  • [6] CRYSTAL-STRUCTURE OF CYCLIN-DEPENDENT KINASE-2
    DEBONDT, HL
    ROSENBLATT, J
    JANCARIK, J
    JONES, HD
    MORGAN, DO
    KIM, SH
    [J]. NATURE, 1993, 363 (6430) : 595 - 602
  • [7] An extensively modified version of MolScript that includes greatly enhanced coloring capabilities
    Esnouf, RM
    [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 1997, 15 (02) : 132 - +
  • [8] FERRACINI R, 1990, ONCOGENE RES, V5, P205
  • [9] A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase
    Fox, T
    Coll, JT
    Xie, XL
    Ford, PJ
    Germann, UA
    Porter, MD
    Pazhanisamy, S
    Fleming, MA
    Galullo, V
    Su, MSS
    Wilson, KP
    [J]. PROTEIN SCIENCE, 1998, 7 (11) : 2249 - 2255
  • [10] The role of the linker between the SH2 domain and catalytic domain in the regulation and function of Src
    Gonfloni, S
    Williams, JC
    Hattula, K
    Weijland, A
    Wierenga, RK
    Superti-Furga, G
    [J]. EMBO JOURNAL, 1997, 16 (24) : 7261 - 7271